Skip to main content

PROVINCIAL DRUG COVERAGE – ONTARIO

AS OF March 2026

Coverage is under constant review and is subject to change.

Access to a generic or biosimilar equivalent is generally reported to be identical to that of the relevant brand name medication.

TYPE OF LISTING

ONTARIO COVERAGE

Bisphosphonates

Etidronate

Didronel; Generics Available

Not in Drug Formulary

Alendronate

Fosamax; Generics Available

Regular Benefit (10mg Generics, 70mg Generics);

Limited Coverage (Fosamax 70 mg);


Non-Benefit (Fosamax 10mg, All 5mg)

Fosavance; Generics Available

Regular Benefit (Generics);
Limited Coverage (Fosavance)

Risedronate

Actonel; Generics Available

Regular Benefit (5mg Generics, All 30mg, All 35mg, All 150mg);

Limited Coverage (Actonel 150mg);

Non-Benefit (Actonel 5mg, Actonel 30mg)

Actonel; DR

Regular Benefit (Generics);
Limited Coverage (Actonel DR)

Zoledronic Acid

Aclasta; Generics Available

Regular Benefit (4mg inj Generics except Zometa Concentrate);
Limited Coverage (5mg inj)

SERMs

Raloxifene

Evista; Generics Available

Limited Coverage

Teriparatide (PTH)

Forteo; Generics Available

Limited Coverage

Osnuvo (biosimilar)

Limited Coverage

Denosumab

Prolia

Limited Coverage

Jubbonti (biosimilar)

Limited Coverage

Stoboclo (biosimilar)

Limited Coverage

Osenvelt (biosimilar)

Limited Coverage

Romosozumab

Evenity

Limited Coverage

Click to view further information on available coverage in Ontario:

Ontario Drug Benefit Formulary/Comparative Drug Index

© Osteoporosis Canada, 2026
Charitable Registration No. 89551 0931 RR 0001